M1393 – Patients who were not diagnosed with recurrent melanoma during the current performance period
HCPCS Level II code · M codes: Medical Services and Quality Measures
HCPCS codeM1393
- Long description
- Patients who were not diagnosed with recurrent melanoma during the current performance period
- Short description
- Pr no dx rec mlnm
- Pricing indicator
00Not separately priced by Part B (bundled, not covered or Part A only)- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
Z2Undefined codes- Added
- January 1, 2025
- Last change
- January 1, 2025 – No change
Frequently asked questions
What is HCPCS code M1393?
M1393 is a HCPCS Level II code for patients who were not diagnosed with recurrent melanoma during the current performance period.
Does Medicare cover M1393?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby M codes
- M1384 – Patients who died during the performance period
- M1385 – Documentation of patient reasons for patients who were not seen for the second pam survey (e.g., less than four months between baseline pam assessment and follow-up
- M1386 – Patients with an excisional surgery for melanoma or melanoma in situ in the past 5 years with an initial ajcc staging of 0, i, or ii at the start of the performance period
- M1387 – Patients who died during the performance period
- M1388 – Patients with documentation of an exam performed for recurrence of melanoma
- M1390 – Patients who do not have a documented exam performed for recurrence of melanoma or no documentation within the performance period
- M1391 – All patients who were diagnosed with recurrent melanoma during the current performance period
- M1392 – Documentation of patient reasons for no examination, i.e., refusal of examination or lost to follow-up (documentation must include information that the clinician was unable to reach the patient by phone, mail or secure electronic mail - at least one method must be documented)
- M1394 – Stages i-iii breast cancer
- M1395 – Patients receiving an initial chemotherapy regimen with a defined duration with the eligible clinician or group
- M1396 – Patients on a therapeutic clinical trial
- M1397 – Patients with recurrence/disease progression
- M1398 – Patients with baseline and follow-up promis surveys documented in the medical record
- M1399 – Patients who leave the practice during the follow-up period
- M1400 – Patients who died during the follow-up period
- M1401 – Stages i-iii breast cancer
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.